Case:Mr T from Myanmar
Age:
62 years old
Nationality:
Myanmar
Diagnosis:
Motor neuron diseases
First Admission Date:
March 2017
Second Admission Date:
July 2017
Background

Mr. T is a prestigious entrepreneur and philanthropist in Myanmar. He gave multiple donations to build a number of temples, bridges, schools, nursing homes, and has been repeatedly reported by domestic and foreign media. However, when confronting with severe illness, he is also fragile. He was diagnosed with Motor Neuron Disease (MND, also known as ALS) in January 2014. After diagnosis, he went for treatment in the United States, Germany, Japan, Singapore, Thailand, but no significant improvement has been obtained.

Patient’s family member consulted our stem cells treatment department in January 2017. Our medical expert team went to the patient's national army hospital in March 2017 and conducted four times biological treatment as first round of treatment. After that, the patient’s symptoms improved significantly and the conditions is under controlled. The patient accepted a second round of treatment in July 2017.

Pre-Treatment Condition(Before Stem Cell Treatment)
  • 1. Patient has breathing difficulty; tongue muscle atrophied and cannot be extended extraoral; speech blurred and blunt; drooling frequently and unable to swallow.
  • 2. Liquid food fed via PEG tube, solid food fed through mouth with difficulty. It takes 30 minutes for each meal, cannot drink through mouth, otherwise he could be choked easily.
  • 3. Weak muscle strength, unable to lift upper limbs, unable to hold or grab anything by each hand, unable to bend and stretch his fingers, unable to move, bend or stretch his legs, and both feet are tip-toed.
  • 4. Coldness of four limbs, severe muscle atrophy of four limbs, remarkable muscular atrophy of thenar eminence, hypothenar eminence, palmar interossei, upper limbs, scapular muscles, and leg muscles.
  • 5. Stiffness of whole body, fatigue, poor mental state, poor sleep quality.
Treatment Plan
  • Two courses of stem cell therapy
  • Surgical method: lumbar puncture + Intravenous infusion
  • Efficacy monitoring plan over 6 to 12 months post-treatment
After the First Course ofTreatment (6 months)
After the Second Course ofTreatment (12 months)


Symptom Improvement
Severe difficulty; tongue atrophy; ventilator-dependent. Voluntarily discontinued ventilator; independent breathing 1.25 hours; reduced lung inflammation.
Liquid via PEG tube; 30-min meals; choking risk. Enhanced lip closure/chewing; reduced choking; upbeat mood & appetite.
Arms: Unable to lift/hold. - Legs: Tip-toed; no movement. Restored foot reflex; reduced muscle tone; feet flat for balance; improved mobility.
Severe atrophy (limbs, hands); cold extremities. Warmer limbs via acupoint therapy; improved circulation for tissue repair.
Stiffness, fatigue, poor sleep, low mental state. Body relaxation; excellent mental state; boosted confidence.
Progress Summary & Future Outlook

Looking ahead, the patient's current positive progress holds great promise. In the coming weeks, with continuous rehabilitation training, the respiratory function is likely to improve further, enabling even longer periods of independent breathing. The swallowing function may fully recover, allowing a more diverse diet. The limb strength will probably continue to strengthen, facilitating normal daily activities. With the enhanced self-confidence, the patient will be more motivated to embrace the recovery journey.

Have any questions?
Please contact us, our team will be happy to assist you.
Appointment Online Communication